Reproductive endpoints in general toxicity studies: are they predictive?

Area of Science:

• Toxicology
• Reproductive Toxicology
• Preclinical Safety Assessment

Background:

• General toxicity studies often include reproductive system assessments.
• Predicting definitive reproductive toxicity early can optimize resource allocation.
• Existing methods for predicting reproductive toxicity have limitations.

Purpose of the Study:

• To evaluate the utility of necropsy and in-life vaginal cytology data from 90-day toxicity studies.
• To determine if these data can predict outcomes of definitive reproductive toxicity tests.
• To assess the concordance between general toxicity findings and the Reproductive Assessment by Continuous Breeding (RACB) design.

Main Methods:

• Data from 18 compounds tested by the National Toxicology Program were analyzed.
• Sperm motility and vaginal cytology evaluations (SMVCE) were conducted at the end of 90-day toxicity studies.
• Results were compared with outcomes from definitive Reproductive Assessment by Continuous Breeding (RACB) studies.

Main Results:

• Thirteen out of 18 compounds showed consistent classifications between the 90-day toxicity study data and the RACB design.
• Discrepancies in five compounds were attributable to differences in dosage or evaluated endpoints.
• Necropsy data from general toxicity studies demonstrated predictive value for reproductive toxicity.

Conclusions:

• Necropsy and in-life cytology data from general toxicity studies offer a valuable preliminary assessment of reproductive toxicity.
• This predictive approach can guide decisions regarding more definitive reproductive toxicity testing.
• The findings support the integration of specific endpoints in general toxicity studies for early reproductive risk identification.